Trial Information
A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724